Andrea Cippitelli

Phoenix Pharmalabs, Inc.

$369,679

Attributed

$739,358

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $419.4K · FY2023–24

$500K$375K$250K$125K$0

'23

'24

Funding mix

By agency

NIH$739,358 · 2

By mechanism

R21$419,375 · 1

R41$319,983 · 1

Top collaborators

Janet D Robishaw1 shared
Lawrence R Toll1 shared

Most similar at Phoenix Pharmalabs, Inc.

Same institution · by research overlap

Daniel Levy$2,894,503

Others in their field

Other Rising Stars on “Exposure To”

Rebecca Montalvan · Westat, Inc.$86,600,000
Dawn Fallacara · Battelle Centers/Pub Hlth Res & Evaluatn$24,046,022
Suma Babu · Massachusetts General Hospital$15,344,018
Sabrina Paganoni · Massachusetts General Hospital$15,344,018
Daniel Hunter Reirden · Westat, Inc.$15,038,020
Xuping Xie · University Of Texas Med Br Galveston$13,737,799

Research focus

Exposure ToFutureMaleFemaleAnimalsExperimental StudyFamilyLigandsBehavioralAffinityAnimal ModelAnalgesicsAffectAntagonistAdme StudyAllodyniaBaseAlcoholsAdverse EffectsBehaviorAttentionBehavior ObservationBiochemicalAstrocytes

Grant awards (2)

The involvement of GPR37L1 on a chronic migraine-like state$419,375

R21 · FY2024 · NS · contact PI

Identification of Mixed NOP/mu partial agonists as lead compounds for treatment of methamphetamine use disorder$319,983

R41 · FY2023 · DA · contact PI